{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:46:36Z","timestamp":1787600796757,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.hrtlng.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T22:47:55Z","timestamp":1649976475000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory"],"prefix":"10.1016","volume":"55","author":[{"given":"Yunfei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchang","family":"Hei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjiang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hrtlng.2022.04.002_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020922129","article-title":"Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertension","volume":"10","author":"Zhu","year":"2020","journal-title":"Pulm Circ"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0002","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5152\/eurjrheum.2018.17052","article-title":"Frequency of pulmonary hypertension in transthoracic echocardiography screening is not increased in Takayasu arteritis: Experience from a single center in Turkey","volume":"5","author":"Kalfa","year":"2018","journal-title":"Eur J Rheumatol"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.04.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010456","article-title":"Increased expression of MicroRNA-206 inhibits potassium voltage-gated channel subfamily a member 5 in pulmonary arterial smooth muscle cells and is related to exaggerated pulmonary artery hypertension following intrauterine growth retardation in rats","volume":"8","author":"Lv","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.04.002_bib0004","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4949","article-title":"FGF21 attenuates hypoxiainduced dysfunction and inflammation in HPAECs via the microRNA27bmediated PPARgamma pathway","volume":"47","author":"Yao","year":"2021","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1016\/j.hrtlng.2022.04.002_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrcardio.2014.191","article-title":"Early detection of pulmonary arterial hypertension","volume":"12","author":"Lau","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"10.1016\/j.hrtlng.2022.04.002_bib0006","first-page":"1541","article-title":"[Diagnosis of pulmonary artery hypertensions]","volume":"41","author":"Laaban","year":"1991","journal-title":"Rev Prat."},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.002_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.12669\/pjms.331.10913","article-title":"Pulmonary arterial hypertension in critically ill elderly patients","volume":"33","author":"Zhang","year":"2017","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0008","volume":"26","author":"He","year":"2020","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1007\/s10528-021-10053-y","article-title":"LncRNA HOXA-AS3 promotes the progression of pulmonary arterial hypertension through mediation of miR-675-3p\/PDE5A Axis","author":"Li","year":"2021","journal-title":"Biochem Genet"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.04.002_bib0010","first-page":"589","article-title":"Downregulation of long noncoding RNA ANRIL promotes proliferation and migration in hypoxic human pulmonary artery smooth muscle cells","volume":"21","author":"Wang","year":"2020","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.04.002_bib0011","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1159\/000480218","article-title":"Long non-coding RNA MEG3 downregulation triggers human pulmonary artery smooth muscle cell proliferation and migration via the p53 signaling pathway","volume":"42","author":"Sun","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.002_bib0012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-020-1143-7","article-title":"Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2","volume":"19","author":"Zhan","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.002_bib0013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-017-0737-1","article-title":"Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122","volume":"16","author":"Su","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0014","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.gene.2017.12.017","article-title":"Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion","volume":"645","author":"Li","year":"2018","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/bab.1764","article-title":"Circulating long non-coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non-small cell lung cancer","volume":"66","author":"Kamel","year":"2019","journal-title":"Biotechnol Appl Biochem"},{"issue":"7","key":"10.1016\/j.hrtlng.2022.04.002_bib0016","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00011-020-01348-8","article-title":"LncRNA promoted inflammatory response in ischemic heart failure through regulation of miR-455-3p\/TRAF6 axis","volume":"69","author":"Gu","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2016259","article-title":"Long noncoding RNA SOX2-OT exacerbates hypoxia-induced cardiomyocytes injury by regulating miR-27a-3p\/TGFbetaR1 axis","volume":"2020","author":"Yang","year":"2020","journal-title":"Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0018","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/1878-0261.12875","article-title":"LncRNA SOX2-OT regulates AKT\/ERK and SOX2\/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases","volume":"15","author":"Herrera-Solorio","year":"2021","journal-title":"Mol Oncol"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0019","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J."},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/0366-6999.199829","article-title":"Clinical study of acute vasoreactivity testing in patients with chronic thromboembolic pulmonary hypertension","volume":"130","author":"Xu","year":"2017","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0021","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.201105-0848OC","article-title":"Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension","volume":"185","author":"Minai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4939-7471-9_6","article-title":"The emerging role of long noncoding RNAs in human disease","volume":"1706","author":"DiStefano","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.hrtlng.2022.04.002_bib0023","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/bcp.14676","article-title":"Riociguat: clinical research and evolving role in therapy","volume":"87","author":"Klinger","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0024","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtn.2019.08.026","article-title":"Circular RNA hsa_circ_0016070 is associated with pulmonary arterial hypertension by promoting PASMC proliferation","volume":"18","author":"Zhou","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.002_bib0025","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-019-13139-9","article-title":"A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension","volume":"10","author":"Arnold","year":"2019","journal-title":"Nat Commun"},{"issue":"146","key":"10.1016\/j.hrtlng.2022.04.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0093-2017","article-title":"Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled","volume":"26","author":"Hemnes","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.04.002_bib0027","doi-asserted-by":"crossref","first-page":"H377","DOI":"10.1152\/ajpheart.00717.2019","article-title":"LncRNA-SMILR modulates RhoA\/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension","volume":"319","author":"Lei","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0028","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3389\/fphar.2020.01140","article-title":"Regulatory mechanisms of lncRNAs and their target gene signaling pathways in laryngeal squamous cell carcinoma","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0029","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.biopha.2017.03.104","article-title":"Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma","volume":"90","author":"Zhang","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.hrtlng.2022.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s13577-021-00572-6","article-title":"Exosomal long non-coding RNA SOX2 overlapping transcript enhances the resistance to EGFR-TKIs in non-small cell lung cancer cell line H1975","volume":"34","author":"Zhou","year":"2021","journal-title":"Hum Cell"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0031","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.3892\/mmr.2017.7244","article-title":"Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.002_bib0032","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/gtmb.2018.0103","article-title":"Identification of an exosomal long noncoding RNA SOX2-OT in plasma as a promising biomarker for lung squamous cell carcinoma","volume":"23","author":"Teng","year":"2019","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"10.1016\/j.hrtlng.2022.04.002_bib0033","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5152\/akd.2015.5834","article-title":"Six-minute walk test in pulmonary arterial hypertension","volume":"15","author":"Demir","year":"2015","journal-title":"Anatol J Cardiol"},{"issue":"13","key":"10.1016\/j.hrtlng.2022.04.002_bib0034","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/ars.2018.7673","article-title":"Focus on early events: pathogenesis of pulmonary arterial hypertension development","volume":"31","author":"Rafikova","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s11658-020-00215-y","article-title":"LncRNA CASC2 inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation and migration by regulating the miR-222\/ING5 axis","volume":"25","author":"Han","year":"2020","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0036","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.omtn.2020.05.022","article-title":"Overexpression of MicroRNA-340-5p inhibits pulmonary arterial hypertension induced by APE by downregulating IL-1beta and IL-6","volume":"21","author":"Ou","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.002_bib0037","doi-asserted-by":"crossref","first-page":"L39","DOI":"10.1152\/ajplung.2001.280.1.L39","article-title":"Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension","volume":"280","author":"Fujita","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.04.002_bib0038","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","article-title":"Interleukin-6 overexpression induces pulmonary hypertension","volume":"104","author":"Steiner","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0039","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yjmcc.2019.03.002","article-title":"Mir-455-3p-1 represses FGF7 expression to inhibit pulmonary arterial hypertension through inhibiting the RAS\/ERK signaling pathway","volume":"130","author":"Zhou","year":"2019","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.hrtlng.2022.04.002_bib0040","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11857","article-title":"Long noncoding RNA NEAT1 promotes pulmonary fibrosis by regulating the microRNA4553p\/SMAD3 axis","volume":"23","author":"Liu","year":"2021","journal-title":"Mol Med Rep"},{"issue":"18","key":"10.1016\/j.hrtlng.2022.04.002_bib0041","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1093\/emboj\/16.18.5509","article-title":"The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p\/Uba2p heterodimer","volume":"16","author":"Johnson","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.hrtlng.2022.04.002_bib0042","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pupt.2019.01.007","article-title":"SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension","volume":"55","author":"Yao","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.002_bib0043","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2015.2209","article-title":"Increased SUMO-1 expression in response to hypoxia: Interaction with HIF-1alpha in hypoxic pulmonary hypertension","volume":"36","author":"Jiang","year":"2015","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.hrtlng.2022.04.002_bib0044","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1139\/bcb-2019-0381","article-title":"Circ_BMP2K enhances the regulatory effects of miR-455-3p on its target gene SUMO1 and thereby inhibits the activation of cardiac fibroblasts","volume":"98","author":"Zhang","year":"2020","journal-title":"Biochem Cell Biol"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014795632200084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014795632200084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:39:00Z","timestamp":1758955140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014795632200084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"alternative-id":["S014795632200084X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2022.04.002","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}